DOI: 10.1001/jamadermatol.2024.0390 ISSN: 2168-6068
Keratoacanthoma and Cutaneous Squamous Cell Carcinoma With PD-1 and PD-L1 Inhibitor Use
Pushkar Aggarwal, Denise Clark, Aatman Shah, Kyle Rismiller, Scott A. Neltner- Dermatology
This cross-sectional study assesses risk of dermatological immune-related adverse events associated with immunotherapy for cancer.